Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells.
Our previous studies have demonstrated that epidermal growth factor (EGF) can induce cell migration through the induction of cysteine-rich protein 61 (Cyr61) in human anaplastic thyroid cancer (ATC) cells. The aim of the present study was to determine the inhibitory effects of combined treatment wit...
Main Authors: | Li-Han Chin, Sung-Po Hsu, Wen-Bin Zhong, Yu-Chih Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4351011?pdf=render |
Similar Items
-
Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells.
by: Li-Han Chin, et al.
Published: (2017-01-01) -
A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model
by: Wen-Bin Zhong, et al.
Published: (2018-06-01) -
Molecular Mechanisms of Lovastatin-Induced Anti-cancer Effect in Human Anaplastic Thyroid Cancer Cells
by: Wen-Bin Zhong, et al.
Published: (2003) -
Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer
by: Mei-Chieh Chen, et al.
Published: (2017-12-01) -
The role of cysteine-rich protein 61 implicates in rheumatoid arthritis
by: Cheng-Yu Chen, et al.
Published: (2016)